Statistical Measurement [Domain] Statistical Measurement [Domain] Award Timing Predetermined Award Timing Predetermined [Flag] Stock issued on exercise of warrants (shares) Stock and Warrants Issued During Period, Shares, Warrants Exercised Stock and Warrants Issued During Period, Shares, Warrants Exercised Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Leases [Abstract] Recently Adopted Accounting Pronouncements and Recently Issued but Not yet Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Accounts payable Increase (Decrease) in Accounts Payable Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Warrants prior to conversion (in shares) Class of Warrant or Right, Outstanding Net income (loss) per share - basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount Principles of Consolidation Consolidation, Policy [Policy Text Block] Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Stock options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Grantee Status [Domain] Grantee Status [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Share-based compensation Share-Based Payment Arrangement, Expense Common stock, shares authorized (in shares) Common Stock, Shares Authorized Current assets: Assets, Current [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders' equity Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Cover [Abstract] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Maximum Maximum [Member] Exercisable at period end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price General and administrative General and Administrative Expense [Member] CT-95 CT-95 [Member] CT-95 Accounting Policies [Abstract] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Operating lease liability Operating Lease, Liability Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Future minimum payments due Lessor, Operating Lease, Payment to be Received Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Entity Shell Company Entity Shell Company Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Warrants exercised (shares) Class of Warrant or Right, Number Of Warrants Exercised Class of Warrant or Right, Number Of Warrants Exercised Statement of Stockholders' Equity [Abstract] Remaining lease term Lessee, Operating Lease, Remaining Lease Term Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Name Measure Name Share-Based Payment Arrangement, Expensed and Capitalized, Amount Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Operating lease liability - current Operating Lease, Liability, Current Document Fiscal Period Focus Document Fiscal Period Focus Award Timing Method Award Timing Method [Text Block] Award Type [Axis] Award Type [Axis] Total assets Assets Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Share-based Compensation Share-Based Payment Arrangement [Policy Text Block] Trading Symbol Trading Symbol Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Other segment items Segment Reporting, Other Segment Item, Amount Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Fees and expenses to be paid to the plaintiff Loss Contingency, Damages Awarded, Value Financial assets Assets, Fair Value Disclosure [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Research and development Research and Development Expense (Excluding Acquired in Process Cost) Warrants Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Integral Integral Molecular, Inc. [Member] Integral Molecular, Inc. Right-of-use asset obtained in exchange for lease obligation Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Outstanding at beginning of period ( in shares) Outstanding at period end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] PEO PEO [Member] Interest income Investment Income, Interest Issued in connection with 2021 initial public offering Issued to Placement Agents [Member] Issued to Placement Agents Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Expected stock price volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Sale of Stock [Domain] Sale of Stock [Domain] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] CT-202 Lonza License Agreement CT-202 Lonza License Agreement [Member] CT-202 Lonza License Agreement Organization, Consolidation and Presentation of Financial Statements [Abstract] Employer contribution amount Defined Contribution Plan, Employer Discretionary Contribution Amount Reduction in the carrying amount of operating lease right-of-use asset Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Vested and expected to vest at March 31, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities, Current Term of renewal options available Lessee, Operating Lease, Term Of Renewal Options Available Lessee, Operating Lease, Term Of Renewal Options Available Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative General and Administrative Expense Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Subsequent event Subsequent Event [Member] Schedule of Assumptions Used to Determine Fair Value of Share-Based Awards Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Vested and expected to vest at period end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Money market funds Money Market Funds [Member] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Research and Development, Contract to Perform for Others [Table] Equity Components [Axis] Equity Components [Axis] Entity Ex Transition Period Entity Ex Transition Period Advance notice required Operating Lease, Renewal Term, Advance Notice Required Operating Lease, Renewal Term, Advance Notice Required Organization and Description of Business Nature of Operations [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Other Performance Measure, Amount Other Performance Measure, Amount Weighted Average Exercise Price Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Patent Costs Patent Costs, Policy [Policy Text Block] Patent Costs, Policy Total current liabilities Liabilities, Current Individual: Individual [Axis] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Maximum development and regulatory milestone payments Collaborative Arrangement, Rights and Obligations, Development And Regulatory Milestone Payments, Maximum Collaborative Arrangement, Rights and Obligations, Development And Regulatory Milestone Payments, Maximum Research and development Research and Development Expense [Member] At The Market Facility At The Market Facility [Member] At The Market Facility Cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Operating lease right-of-use lease asset Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current Rent expense Operating Lease, Cost Expected period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Reportable Segment Reportable Segment [Member] Reportable Segment Additional milestone payments that may be due Asset Acquisition, Contingent Consideration, Liability Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] CT-202 CT-202 [Member] CT-202 Class of Warrant or Right [Table] Class of Warrant or Right [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Leases Lessee, Leases [Policy Text Block] Depreciation and amortization expense Depreciation, Depletion and Amortization Entity Central Index Key Entity Central Index Key PEO Name PEO Name Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Supplemental disclosure of non-cash activities: Supplemental Cash Flow Elements [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Arrangement Duration Trading Arrangement Duration Warrant exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Segments [Axis] Segments [Axis] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of lease renewals Operating Lease, Number Of Renewals Operating Lease, Number Of Renewals Subsequent Event Type [Axis] Subsequent Event Type [Axis] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Assets Assets [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Other Commitments [Axis] Other Commitments [Axis] Fair Value Measurements Fair Value Disclosures [Text Block] Stockholders' equity: Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Mootness Fee Mootness Fee [Member] Mootness Fee Maximum sales milestone payments Collaborative Arrangement, Rights and Obligations, Sales Milestone Payments, Maximum Collaborative Arrangement, Rights and Obligations, Sales Milestone Payments, Maximum Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Aggregate offering amount Sale of Stock, Aggregate Offering Amount Sale of Stock, Aggregate Offering Amount Deferred Offering Costs Deferred Charges, Policy [Policy Text Block] Operating lease liability - non-current Operating Lease, Liability, Noncurrent Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Operating lease discount rate (percent) Lessee, Operating Lease, Discount Rate Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest [Abstract] Personnel-related costs Labor and Related Expense Risks And Liquidity [Abstract] Risks And Liquidity Document Quarterly Report Document Quarterly Report Reconciliation of Other Items from Segments to Consolidated Segment, Reconciliation of Other Items from Segments to Consolidated [Table Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Emerging Growth Company Status Emerging Growth Company Status [Policy Text Block] Emerging Growth Company Status Counterparty Name [Domain] Counterparty Name [Domain] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Outstanding at beginning of period Outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Temporary Equity Disclosure [Abstract] Restatement Determination Date: Restatement Determination Date [Axis] Number of licensed antibodies to be commercialized Collaboration And License Agreements, Number Of Licensed Antibodies Collaboration And License Agreements, Number Of Licensed Antibodies Non-PEO NEO Non-PEO NEO [Member] 46023 Outstanding at March 31, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Sale of Stock [Axis] Sale of Stock [Axis] Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] Equity Awards Adjustments Equity Awards Adjustments [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Recovery of Erroneously Awarded Compensation Disclosure [Line Items] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] CTIM-76 CTIM-76 [Member] CTIM-76 Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items] Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Development milestone achieved Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross Employer matching contribution, percent of employees compensation Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Vested and expected to vest at March 31, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Minimum Minimum [Member] Number of securities called by warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Company Selected Measure Name Company Selected Measure Name Issued in connection with 2021 private placement December 2021 Private Placement Agent Warrants [Member] December 2021 Private Placement Agent Warrants Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Common stock, $0.001 par value; 200,000,000 shares authorized at March 31, 2026 and December 31, 2025; 91,879,177 shares issued and outstanding at March 31, 2026 and December 31, 2025 Common Stock, Value, Issued New employee Share-Based Payment Arrangement, Employee [Member] Commitment and Contingencies, including License Agreements Commitments and Contingencies Disclosure [Text Block] Weighted average common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Research and development costs Accrued Research and Development Costs, Current Accrued Research and Development Costs, Current Segment Information Segment Reporting, Policy [Policy Text Block] Commitments and contingencies (Note 8) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Entity Small Business Entity Small Business Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Common Stock Common Class A [Member] Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Uninsured amount Cash, Uninsured Amount Vested and exercisable at March 31, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Operating lease liability Increase (Decrease) in Operating Lease Liability Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Name Outstanding Recovery, Individual Name Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Payment of offering costs from the sale of common stock from ATM facility Proceeds from Issuance of Common Stock Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] All Individuals All Individuals [Member] Fair Value Disclosures [Abstract] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment One-time payment made to the Seller Asset Acquisition, Consideration Transferred Vested and expected to vest at period end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Name Forgone Recovery, Individual Name Share-based award contractual life Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Accrued contingency Loss Contingency Accrual Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Private Placement Private Placement [Member] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities: Liabilities, Current [Abstract] Weighted Average Remaining Contractual Term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities Net income (loss) per share - diluted (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Title of 12(b) Security Title of 12(b) Security Vested and exercisable at March 31, 2026 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Number of shares issued in transaction Sale of Stock, Number of Shares Issued in Transaction Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Segment, Reconciliation of Other Items from Segments to Consolidated [Table] Segment, Reconciliation of Other Items from Segments to Consolidated [Table] Deferred offering costs Deferred Offering Costs Lonza Sales Lonza Sales [Member] Lonza Sales Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Award Timing Disclosures [Line Items] Common stock purchase price for each warrant (in usd per share) Class of Warrant or Right, Purchase Price Class of Warrant or Right, Purchase Price Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Compensation and benefits Employee-related Liabilities, Current Additional renewal term Lessee, Operating Lease, Renewal Term Stockholders' Equity Equity [Text Block] Net loss Net loss Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date Other Commitments [Domain] Other Commitments [Domain] Other Other Accrued Liabilities, Current Share-based awards vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Property and equipment, net Property, Plant and Equipment, Net Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss from operations Operating Income (Loss) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Risks and Liquidity Risks And Liquidity [Text Block] Risks And Liquidity Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Accrued contingency Loss Contingency, Accrual, Current Class of Stock [Axis] Class of Stock [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Maximum annual contributions per employee, percent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Event Type [Domain] Subsequent Event Type [Domain] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Payables and Accruals [Abstract] Shares of common stock available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Professional fees Professional Fees Statement [Table] Statement [Table] Other income (expense) Other Nonoperating Income (Expense) Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Weighted average fair value of grants during period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Antidilutive securities excluded from computation of diluted weighted-average shares of common stock outstanding Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Total shares of common stock authorized for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Termination Date Trading Arrangement Termination Date Cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Annual rate at which authorized shares of common stock increase Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized As A Percentage Of Outstanding Stock Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized As A Percentage Of Outstanding Stock Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Schedule of Share-Based Award Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Weighted average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Issued in connection with 2024 private placement Issued In Connection With Private Placement [Member] Issued In Connection With Private Placement Receivable Loss Contingency, Receivable Exercisable at period end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Entity Tax Identification Number Entity Tax Identification Number Grantee Status [Axis] Grantee Status [Axis] BioAtla, Inc. [Member] BioAtla, Inc. [Member] BioAtla, Inc. Outstanding at beginning of period (in dollars per share) Outstanding at period end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Options granted (in shares) Granted during the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Tiered royalty payment, percent (up to) Collaborative Arrangement, Rights and Obligations, Tiered Royalty, Percent Collaborative Arrangement, Rights and Obligations, Tiered Royalty, Percent Use of Estimates Use of Estimates, Policy [Policy Text Block] Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Issued in 2022 for consulting services Issued for Professional Consulting Services [Member] Issued for Professional Consulting Services Total liabilities Liabilities Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Acquired-In-Process Research and Development Costs In Process Research and Development, Policy [Policy Text Block] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Statement [Line Items] Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Counterparty Name [Axis] Counterparty Name [Axis] Common Stock Common Stock [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Net decrease in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Professional fees Accrued Professional Fees, Current